Jonathan Smith
Reporter for Labiotech. I hail from the UK. I was born in Bristol, studied Neuroscience in the University of Bristol, and trained mice in Eisai, Hertfordshire, for one year. I then tickled locusts for my Ph.D. at the University of Leicester, before eventually ending up here! Out of the office, I travel, play video games and board games, drink beer and play the piano.
Can Biotechnology Reduce Animal Testing in Medicine?
CSL Behring Nabs UniQure’s Hemophilia Gene Therapy for up to €1.8B
Democratized DNA Synthesis: A Game-Changer Against Covid-19
French Manufacturing Plant Launches to Make Cell Therapy Cheap and Scalable
What Did European Oncology Players Offer at ASCO 2020?
Argenx Follows up Phase III Success with Giant €785M Global Offering
Argenx’s Rare Disease Treatment Strikes Gold in Phase III
What 2019 Can Teach About European Biotech Investments Going Forward
Update: Novartis’ Gene Therapy Zolgensma Gets Nod from EU
Gamida Cell’s Bone Marrow Transplant Cuts Treatment Time in Phase III
